Translating advanced diffusion MRI for clinical neuroimaging: breakthroughs and current challenges
Imaging Neuroscience · 12.11.2026
DOI: 10.1162/imag.a.1480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Imaging Neuroscience, online erschienen am 12.11.2026. Verfasst von Kouhei Kamiya und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diffusion magnetic resonance imaging (dMRI) has transformed clinical neuroimaging through its unique sensitivity to pathology and its ability to visualize white matter connections noninvasively. In research settings, recent decades have seen substantial technical advances, yielding deeper insights into brain microstructure in health and disease as well as into the link between brain connectivity and function. Nevertheless, few of these advanced techniques have entered routine patient-level clinical practice, and the gap between frontline clinicians and the research community continues to widen. The present article aims to aid communication across this divide, in the belief that clinically usable tools will arise only from such dialogue. We first review the historical breakthroughs of dMRI in clinical neuroimaging and draw on them to identify the barriers to translation. As with biomarkers in general, the bottleneck is demonstrating clinical utility—a net improvement in health outcomes or clinical decision-making relative to the current standard of care. We then examine recent applications in research to clarify why the pursuit of clinical utility is necessarily slow and incremental. We further discuss two properties desirable in a clinical tool—broad accessibility and biological interpretability—and the advantages and limitations of signal representations and biophysical models from the perspective of translation. Finally, we outline the challenges and open questions surrounding the clinical implementation of advanced dMRI. The history suggests that a killer application in routine practice, like apparent diffusion coefficient in acute brain ischemia, is not an endpoint but a stage in a cycle that feeds back into basic science and engineering. Advanced dMRI has yet to enter this virtuous cycle. We hope this article will help sustain motivation through this protracted phase and encourage interdisciplinary exchange in any form.
Zitieren
APA
Kamiya, K., Kurokawa, R., Suzuki, Y., & Hori, M. (2026). Translating advanced diffusion MRI for clinical neuroimaging: breakthroughs and current challenges. Imaging Neuroscience. https://doi.org/10.1162/imag.a.1480
Vancouver
Kamiya K, Kurokawa R, Suzuki Y, Hori M. Translating advanced diffusion MRI for clinical neuroimaging: breakthroughs and current challenges. Imaging Neuroscience. 2026. doi:10.1162/imag.a.1480
BibTeX
@article{Kamiya2026,
author = {Kamiya, Kouhei and Kurokawa, Ryo and Suzuki, Yuichi and Hori, Masaaki},
title = {Translating advanced diffusion MRI for clinical neuroimaging: breakthroughs and current challenges},
journal = {Imaging Neuroscience},
year = {2026},
doi = {10.1162/imag.a.1480}
}
EUVIMED